Y-Intercept (HK)’s CME Group CME Stock Holding History

Y-Intercept (HK)’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$14M	Sell	53,259 -95,086	-64%	-$25.1M	0.31%	43
2026 Q2	$32.8M	Buy	148,345 +137,794	+1,306%	+$38.1M	0.65%	7
2026 Q1	$3.12M	Buy	+10,551	New	+$3.13M	0.06%	513
2025 Q4	–	Sell	-6,663	Closed	-$1.8M	–	1606
2025 Q3	$1.8M	Sell	6,663 -7,321	-52%	-$1.99M	0.04%	673
2025 Q2	$3.85M	Buy	+13,984	New	+$3.8M	0.09%	308
2024 Q3	–	Sell	-17,050	Closed	-$3.35M	–	1369
2024 Q2	$3.35M	Buy	17,050 +8,616	+102%	+$1.78M	0.18%	119
2024 Q1	$1.82M	Buy	+8,434	New	+$1.77M	0.14%	189
2023 Q4	–	Sell	-8,910	Closed	-$1.78M	–	1276
2023 Q3	$1.78M	Buy	+8,910	New	+$1.77M	0.17%	165
2023 Q2	–	Sell	-5,391	Closed	-$1.03M	–	1325
2023 Q1	$1.03M	Buy	+5,391	New	+$975K	0.12%	245
2022 Q4	–	Sell	-3,251	Closed	-$576K	–	1040
2022 Q3	$576K	Buy	+3,251	New	+$642K	0.06%	480
2022 Q2	–	Sell	-3,271	Closed	-$778K	–	899
2022 Q1	$778K	Buy	+3,271	New	+$768K	0.18%	162
2021 Q3	–	Sell	-2,772	Closed	-$590K	–	681
2021 Q2	$590K	Buy	+2,772	New	+$585K	0.15%	218

Other funds holding CME

PineStone Asset Management Montreal, Quebec, Canada $15.4B AUM 14.92% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Y-Intercept (HK)'s CME Position: Q3 2026 in Review

Y-Intercept (HK) reduced its CME Group (CME) stake by 64% in Q3 2026, selling an estimated $25.1M and leaving 53,259 shares worth $14M. The position accounts for 0.31% of the portfolio, ranked #43.

Y-Intercept (HK) first reported a position in CME in Q2 2021 and has held it in 12 quarters since. The position peaked at $32.8M in Q2 2026. 338 funds tracked by Wall St. Rank hold CME as of Q3 2026.

Y-Intercept (HK) held 53,259 shares of CME Group worth $14M as of Q3 2026.
Y-Intercept (HK) sold 95,086 CME Group shares in Q3 2026, an estimated $25.1M.
CME Group made up 0.31% of Y-Intercept (HK)'s portfolio in Q3 2026, its #43 holding.
Y-Intercept (HK) first reported a position in CME Group in Q2 2021 and has held it in 12 quarters since.
Y-Intercept (HK)'s CME Group position peaked at $32.8M in Q2 2026.
338 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.